Arecor Therapeutics (LSE:AREC) Days Sales Outstanding : 187.15 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Arecor Therapeutics Days Sales Outstanding?

Arecor Therapeutics's average Accounts Receivable for the six months ended in Dec. 2023 was £2.98 Mil. Arecor Therapeutics's Revenue for the six months ended in Dec. 2023 was £2.90 Mil. Hence, Arecor Therapeutics's Days Sales Outstanding for the six months ended in Dec. 2023 was 187.15.

The historical rank and industry rank for Arecor Therapeutics's Days Sales Outstanding or its related term are showing as below:

LSE:AREC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 78.46 Med: 120.76 Max: 257.16
Current: 176.13

During the past 7 years, Arecor Therapeutics's highest Days Sales Outstanding was 257.16. The lowest was 78.46. And the median was 120.76.

LSE:AREC's Days Sales Outstanding is ranked worse than
81.19% of 893 companies
in the Biotechnology industry
Industry Median: 73.34 vs LSE:AREC: 176.13

Arecor Therapeutics's Days Sales Outstanding increased from Dec. 2022 (113.66) to Dec. 2023 (187.15).

Arecor Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Arecor Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arecor Therapeutics Days Sales Outstanding Chart

Arecor Therapeutics Annual Data

Trend

May17

May18

May19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

257.16

78.46

124.50

104.50

117.01

Arecor Therapeutics Semi-Annual Data
	May18	May19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial					154.49	286.79	113.66	237.94	187.15

Competitive Comparison of Arecor Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Arecor Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arecor Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arecor Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Arecor Therapeutics's Days Sales Outstanding falls into.

Arecor Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Arecor Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.664	+	2.268)	/	2 )	/	4.573	*	365
=	1.466					/	4.573	*	365
=	117.01

Arecor Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.688	+	2.268)	/	2 )	/	2.904	*	365 / 2
=	2.978					/	2.904	*	365 / 2
=	187.15

Arecor Therapeutics (LSE:AREC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Arecor Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Arecor Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Arecor Therapeutics (LSE:AREC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arecor Therapeutics PLC (LSE:AREC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

6UI:Germany

Address

Chesterford Research Park, Little Chesterford, Saffron Walden, GBR, CB10 1XL

Website

https://www.arecor.com

Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, the Rest of Europe, the USA, India, and the Rest of the World, out of which the majority is from the UK.